{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:13:25Z","timestamp":1792653205285,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/bor.0000000000000007","type":"journal-article","created":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T08:05:33Z","timestamp":1385107533000},"page":"80-84","source":"Crossref","is-referenced-by-count":45,"title":["Arthritis and bone loss"],"prefix":"10.1097","volume":"26","author":[{"given":"Arnd","family":"Kleyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis.","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis.","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1359\/jbmr.090533","article-title":"Osteoclasts and arthritis.","volume":"24","author":"Schett","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone.","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X12438080","article-title":"The role of RANK ligandosteoprotegerin in rheumatoid arthritis.","volume":"4","author":"Geusens","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J Clin Invest"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis.","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2903","article-title":"The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.","volume":"12","author":"Pruijn","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-152-7-201004060-00010","article-title":"Systematic review: accuracy of anticitrullinated peptide antibodies for diagnosing rheumatoid arthritis.","volume":"152","author":"Whiting","year":"2010","journal-title":"Ann Intern Med"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/516736","article-title":"Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis.","volume":"80","author":"Kallberg","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","article-title":"Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis.","volume":"62","author":"Wegner","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anticyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated proteinpeptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CCP status predicts worse disease activity and greater radiological progression.","volume":"64","author":"Ronnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/art.23439","article-title":"Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anticitrullinated protein antibodies in relation to different treatment strategies.","volume":"58","author":"de Vries-Bouwouwstra","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/art.22868","article-title":"The performance of anticyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register.","volume":"56","author":"Bukhari","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated proteinpeptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/rheumatology\/kei203","article-title":"Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.","volume":"45","author":"Quinn","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.2009.113092","article-title":"Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.","volume":"69","author":"Syversen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R24-13-20210128","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/ar3025","article-title":"Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis.","volume":"12","author":"Guler-Yuksel","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/03009740801998812","article-title":"The relationship between anticyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis.","volume":"37","author":"Guler","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/ar2749","article-title":"Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study.","volume":"11","author":"Boyesen","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/art.27252","article-title":"Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography.","volume":"62","author":"Stach","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/ard.2009.125534","article-title":"Radiographic progression and remission rates in early rheumatoid arthritis: MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.","volume":"69","author":"Hetland","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.","volume":"122","author":"Harre","year":"2012","journal-title":"J Clin Invest"},{"key":"R32-13-20210128","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/ard.2010.135723","article-title":"Bone metabolism is altered in preclinical rheumatoid arthritis.","volume":"70","author":"van Schaardenburg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis.","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"key":"R34-13-20210128","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","article-title":"Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at-risk for future clinically apparent disease.","volume":"65","author":"Willis","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T06:31:35Z","timestamp":1716186695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201401000-00013"}},"subtitle":["a hen and egg story"],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000007","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}